| All (n =â50) | Groups | P-value | |
---|---|---|---|---|
TM (n =â25) | HM (n =â25) | |||
Age (mean)â±âSD | 74.84â±â11.8 | 73.68â±â14.2 | 76.00â±â8.8 | 0.68 |
Men (mean) | 26 (52.0) | 13 (52.0) | 13 (52.0) | 1.00 |
MLHFQ [95CI] | 24.58 [19.30;29.86] | 20.20 [14.48;25.92] | 28.96 [19.97â37.95] | 0.07 |
EQ5D utilities [95CI] | 0.78 [0.72;0.85] | 0.81 [0.74;0.87] | 0.76 [0.64;0.88] | 0.47 |
Pacing indication (%) | ||||
âSick sinus syndrome | 24 (48.0) | 12 (48.0) | 12 (48.0) | 0.65 |
âAtrioventricular block | 20 (40.0) | 11 (44.0%) | 9 (36.0) | |
âChronic AF with Bradycardia | 6 (12.0) | 2 (8.0) | 4 (16.0) | |
Disease manifestations (%) | ||||
âSyncope | 14 (28.0) | 8 (32.0) | 6 (24.0) | 0.81 |
âDizziness | 25 (50.0) | 12 (48.0) | 13 (52.0) | |
âDyspnoea | 11 (22.0) | 5 (20.0) | 6 (24.0) | |
Service derivated (%) | ||||
âEmergency dept. | 3 (6.0) | 1 (4.0) | 2 (8.0) | 0.51 |
âCardiology ward | 14 (28.0) | 5 (20.0) | 9 (36.0) | |
âPrimary healthcare | 4 (8.0) | 2 (8.0) | 2 (8.0) | |
âOther hospitals | 29 (58.0) | 17 (68.0) | 12 (48.0) | |
Stimulation (%) | ||||
âDDDR | 44 (88.0) | 23 (92.0) | 21 (84.0) | 0.33 |
âVVIR | 6 (12.0) | 2 (8.0) | 4 (16.0) | |
Comorbidities (%) | ||||
âDislipidemia | 27 (54.0) | 13 (52.0) | 14 (56.0) | 0.50 |
âObesity (BMIâ>â30) | 1 (2.0) | 0 (0.0) | 1 (4.0) | 0.50 |
âTachyarrhythmia | 18 (36.0) | 7 (28.0) | 11 (44.0) | 0.19 |
âHypertension | 32 (64.0) | 17 (68.0) | 15 (60.0) | 0.38 |
âDiabetes Mellitus | 6 (12.0) | 0 (0.0) | 6 (24.0) | 0.01 |
Other comorbidities (%) | ||||
âNone | 18 (36.0) | 11 (44.0) | 7 (28.0) | 0.39 |
âOthers | 10 (20.0) | 6 (24.0) | 4 (16.0) | |
âCoronary heart diseases | 22 (44.0) | 8 (32.0) | 14 (56.0) | |
Pharmaceutical treatment (%) | ||||
âAntiaggregants | 18 (36.0) | 8 (32.0) | 10 (40.0) | 0.38 |
âAnticoagulants | 25 (50.0) | 10 (40.0) | 15 (60.0) | 0.13 |
âAntiarrhythmics | 18 (36.0) | 7 (28.0) | 11 (44.0) | 0.19 |
âAntihypertensives | 32 (64.0) | 18 (72.0) | 14 (56.0) | 0.19 |